Skip to content

Insider · CIK 0001264783

Wilhelmus Cm Groenhuysen

director

Files at OPTN (OptiNose, Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Mar 3, 2025 NVCR
NovoCure Limited
3,165
0.00% of outstanding
$59kMar 3, 2025$7.2M
Feb 28, 2025 NVCR
NovoCure Limited
3,202
0.00% of outstanding
$59kFeb 28, 2025$7.1M
Feb 27, 2025 NVCR
NovoCure Limited
7,211
0.01% of outstanding
$144kFeb 27, 2025$7.0M
Jan 2, 2025 NVCR
NovoCure Limited
266,085
0.25% of outstanding
$7.9MJan 2, 2025none

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 21, 2025OPTN
OptiNose, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-5,000--0May 21, 2025
May 21, 2025OPTN
OptiNose, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-3,566--0May 21, 2025
May 21, 2025OPTN
OptiNose, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-2,133--0May 21, 2025
May 21, 2025OPTN
OptiNose, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-962--0May 21, 2025
May 21, 2025OPTN
OptiNose, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-962--0May 21, 2025
May 21, 2025OPTN
OptiNose, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-962--0May 21, 2025
May 21, 2025OPTN
OptiNose, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-962--0May 21, 2025
May 21, 2025OPTN
OptiNose, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-1,925--0May 21, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Wilhelmus Cm Groenhuysen: insider trades and track record | InsiderTell